Jaguar Health, Inc. JAGX
Jaguar Health, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -398.8% | -263.8% | -351.3% | -287.8% | -939.1% | -283.9% | -501.3% | -698.0% | -785.3% | -9599.8% |
| Net margin | -465.4% | -329.3% | -423.1% | -396.9% | — | -360.2% | -667.3% | -727.9% | -503.7% | -10410.9% |
| FCF margin | — | -251.5% | — | -277.5% | -806.8% | -162.9% | — | -514.9% | — | -10258.4% |
| Return on assets | -139.8% | -72.0% | -81.4% | -100.0% | — | -78.9% | -105.8% | -78.3% | -50.4% | -413.5% |
| Return on equity | 286.7% | -592.7% | -843.4% | 3491.8% | — | -196.5% | -361.1% | -597.2% | -127.3% | 600.4% |
| Debt / equity | — | — | — | — | — | — | — | — | 0.64× | -0.74× |
| Current ratio | 0.50 | 1.63 | 2.00 | 0.74 | 1.84 | 1.35 | 0.62 | 0.31 | 0.25 | 0.61 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.